All blog items

MMCi program travels to Washington, DC to discuss healthcare policy and innovation with industry leaders

The 2017 class of Duke’s Master of Management in Clinical Informatics program recently spent three days in Washington, DC, discussing healthcare policy and innovation with stakeholders from across the industry. Class members participated in round-table discussions and listened to presentations from thirteen industry leaders, including private-sector and nonprofit CEOs, policy advisors and fellows, Department of Defense medical innovation officers, and former congressmen.

Duke Launches Second Enrollment Location for Project Baseline Study

With a study watch on her wrist and a sleep sensor in her new tote bag, a Caucasian woman in her 40s walked out of the Duke University Medical Center around 5:30 p.m. Thursday, July 13 as the first participant enrolled in the Project Baseline study in Durham.

Large-Scale, Collaborative Effort Could Help Ease Global Hearing Loss

Rising rates of hearing loss demand better access to preventions and treatments A team of hearing experts at Duke University School of Medicine and the Duke Global Health Institute is calling for a comprehensive, worldwide initiative to combat hearing loss. The percentage of people worldwide with hearing loss has been on the rise, increasing from 14 percent to 18 percent over the past 25 years. Recent data estimate half a billion people worldwide have moderate to severe hearing losses.

Large-Scale, Collaborative Effort Could Help Ease Global Hearing Loss

Rising rates of hearing loss demand better access to preventions and treatments A team of hearing experts at Duke University School of Medicine and the Duke Global Health Institute is calling for a comprehensive, worldwide initiative to combat hearing loss. The percentage of people worldwide with hearing loss has been on the rise, increasing from 14 percent to 18 percent over the past 25 years. Recent data estimate half a billion people worldwide have moderate to severe hearing losses.

Antibodies Halt Placental Transmission of CMV-Like Virus in Monkeys

The finding advances a human vaccine for CMV, which afflicts 1 million babies a year DURHAM, N.C. – Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments. The virus, one of only a handful known to be transmitted through the mother’s placenta to a fetus, infects nearly 1 million infants a year worldwide and is a leading cause of microcephaly, hearing and/or vision loss, and nervous system damage.